Expect a smooth refit when transitioning your existing clariti® 1 day multifocal wearers into clariti® 1 day multifocal 3 Add with CooperVision Binocular Progressive System®.
When it comes to efficiencies in day-to-day practice, time is invaluable, Chair time. Fit time. Overall patient care time, to name few.
Efficiency is also important in multifocal contact lens fits.1,2 Eye care professionals value efficiency when fitting multifocal contact lenses,1 and so do their patients with presbyopia.2 In fact, 67% of patients with presbyopia don’t want to sit through long appointments or have to return to their eye care professional’s office on repeat to finally get a multifocal contact lens that works for their vision needs.2
clariti® 1 day multifocal has always been easy to fit. Now, you can expect a smooth refit when transitioning your existing clariti® 1 day multifocal wearers into clariti® 1 day multifocal 3 Add with CooperVision Binocular Progressive System®, the same design found in MyDay® multifocal.3,4,5
A Trusted Technology Leads to Seamless Fits1,6,7
The Binocular Progressive System™’s familiar fitting process and fit guide offer eye care professionals a streamlined fit approach and assurance of a high fit success rate.3 At least, 83% of wearers achieve their final prescription with the initial pair of lenses,3,6 and at least 98% of patients fit with clariti® 1 day multifocal lenses are successfully fit with no more than two pairs.3,6,7
Additionally, the Binocular Progressive System™ is designed to deliver optimal visual acuity at all distances, even as your patients’ presbyopia advances.8
This innovative, 3 Add multifocal system is customer-tailored to presbyopes of all stages.8 For early presbyopes, the 3 Add design seamlessly combines low add aspheric centre-near designs with an expansive distance area. As your patient’s presbyopia advances, the system adapts by integrating increasing near support with a strengthened central reading area. For patients with more advanced presbyopia, the system incorporates a high Add lens with a single-powered spherical centre-near zone and dual intermediate power zones. The Binocular Progressive System™ delivers a straightforward fitting process due to its methodical approach and typically involves using a low Add in the dominant eye.
Deliver an Improved Wearing Experience for Your Patients with Presbyopia*†4
Wearers who transitioned from the original 2 Add to the 3 Add design reported improvements in both distance and near visual acuity after just two weeks of daily wear.*4 Additionally, 62% of patients said the transition from the 2 Add to the Binocular Progressive System™ 3 Add was easy†4.
Additionally, your existing clariti® 1 day multifocal wearers can experience improved comfort thanks to the new Optimized Comfort Edge™.9 In a recent study, patients reported the new clariti® 1 day multifocal 3 Add met or exceeded their comfort needs starting on day 1 and provided greater comfort than the current clariti® 1 day multifocal 2 Add. ‡4 Further, patients cited good overall satisfaction with their lens-wearing experience.4
Discover how simple and efficient3,4 it is to transition your current 2 Add patients into the new 3 Add design and offer your patients with presbyopia the advantages of a technology upgrade at the same great value they expect from the clariti® family. Also visit CooperVision’s Online Success Center for additional information and learnings about the new clariti® 1 day multifocal 3 Add.
* Distance logMAR VA -0.05 vs -0.02 (p < 0.01), near VA 0.06 vs 0.11 (p = 0.02) for BPS vs 2 ADD respectively
† 62% rated the transition easy (very/somewhat), p<0.01.
‡ Days 1 and 13, p<0.05.
§ Subject rating for a typical day at 2-week visit.
1. Terrell B, Bull Z, Webley D. Perception of ECPs towards multifocal contact lens fitting. Contact Lens & Anterior Eye. Contact Lens & Anterior Eye. https://doi.org/10.1016/j.clae.2022.101666.
2. CVI data on file, 2020. Kubic Online Survey with spherical soft contact lens wearers with presbyopia/symptoms. N= 399 (227 1 Day, 172 FRP wearers). US, UK, JP; weighted equally.
3. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; n=90 habitual MFCL wearers.
4. CVI data on file, 2022. Prospective, crossover, bilateral, subject masked, daily wear, dispensing study (4 clinical sites in U.S.) (n=58 habitual soft MFCL wearers).
5. CVI data on file, 2022.
6. CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® multifocal; n=58 habitual multifocal contact lens wearers.
7. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® multifocal; n=104 habitual multifocal contact lens wearers.
8. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with ratings from 85 to 89 out of 100; n=90 habitual MFCL wearers.
9. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add with a rating of 88 out of 100; n=90 habitual MFCL wearers.
